ResMed Inc. vs Western Digital Corp — how do they compare? ResMed Inc. trades at $230.57 (market cap $31.89B), while Western Digital Corp trades at $395.29 (market cap $147.23B). The key difference: Western Digital Corp is far larger — about 4.6× ResMed Inc.'s market cap, and ResMed Inc. pays the higher dividend (1.16%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Western Digital Corp for 37 Days on average.
| RMD | WDC | |
|---|---|---|
Market Cap | $31.89B | $147.23B |
Volume | 618,314 | 9,341,468 |
Sector | Health | Technology |
52-Week High | $277.88 | $746.23 |
52-Week Low | $182.82 | $113.13 |
Typical Hold Time | 51 Days | 37 Days |
Enterprise Value | $31.24B | $146.70B |
Dividend Yield | 1.16% | 0.15% |
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $230.91, up 2.18% today, with a bullish technical signal and strong fundamentals. The company reported consistent earnings beats in recent quarters, with Q3 2026 EPS expected at $2.68. Revenue grew to $5.15B in 2025, with a net income margin of 26.94%. Analyst consensus is a buy, with a $242.70 price target. Recent news highlights EPS growth targets of 12%-14% and participation in investor conferences.
Outlook is positive due to robust earnings growth and market share gains, but risks include competitive pressures and regulatory investigations. The stock offers upside to the consensus target, supported by institutional buying and solid cash flow generation.
Western Digital (WDC) trades at $394.13, down 2.73% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with three consecutive earnings beats and robust profitability metrics including 71.97% net margin and 131.02% ROE. Technical indicators are bearish with the price testing key support at $387, while analyst consensus remains strongly bullish with a $647.58 price target representing 64% upside potential.
Despite near-term competitive pressures, WDC's dominant market position in AI storage and improving financial performance support long-term growth prospects. Key risks include pricing pressure from increased industry capacity and execution challenges in maintaining cost-per-terabyte reductions. The current valuation at 14.61 P/E appears attractive relative to growth expectations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →